SCHEMBL6825161

SCHEMBL6825161

CC(=O)Oc1ccccc1C(=O)Oc1ccccc1C(=O)OCc1cnc(N)nc1N

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.49
HSD17B10 Q99714 2/20 0.49
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
PTGS2 P35354 4/20 0.45
ALDH1A1 P00352 1/20 0.41
ESR1 P03372 1/20 0.41
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
HMGB1 P09429 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
GGT1 P19440 1/20 0.41
PTGS1 P23219 1/20 0.41
BLM P54132 1/20 0.41
NAPRT Q6XQN6 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6825659 0.98 KDM4E (0.45) KDM4EHSD17B10LMNACYP1A2CYP2C9
SCHEMBL6821932 0.89 KDM4E (0.47) KDM4EHSD17B10ALDH1A1HPGDTDP1
SCHEMBL6825056 0.81 KDM4E (0.40) KDM4EALDH1A1
SCHEMBL6825053 0.80 TDP1 (0.51) KDM4EALDH1A1TDP1
SCHEMBL6827408 0.79 KDM4E (0.44) KDM4EHSD17B10LMNACYP1A2CYP2C9
SCHEMBL6825657 0.77 DHFR (0.41) KDM4EHSD17B10LMNACYP1A2CYP2C9
SCHEMBL6827422 0.77 KDM4E (0.48) KDM4EHSD17B10LMNACYP1A2CYP2C9
SCHEMBL11646752 0.76 DHFR (0.47)
SCHEMBL6821942 0.75 DHFR (0.48) KDM4EHSD17B10LMNACYP1A2CYP2C9
SCHEMBL6825050 0.75 KDM4E (0.44) KDM4EHSD17B10LMNACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004020417-A1 2,4-DIAMINOQUINAZOLINE, 2-AMINO-4-HYDROXYPTERIDINE AND 2,4-DIAMINOPYRIMIDINE ESTER DERIVATIVES AS DIHYDROFOLATE REDUCTASE INHIBITORS MELACURE THERAPEUTICS AB (SE) 2004-03-11 WO claimed
WO-2004020417-A1 2,4-DIAMINOQUINAZOLINE, 2-AMINO-4-HYDROXYPTERIDINE AND 2,4-DIAMINOPYRIMIDINE ESTER DERIVATIVES AS DIHYDROFOLATE REDUCTASE INHIBITORS MELACURE THERAPEUTICS AB (SE) 2004-03-11 WO disclosed